目的 探討馬來酸麥角新堿在子宮肌瘤剔除術(shù)中的應(yīng)用價(jià)值。方法 將2018年8月-2018年11月新疆醫(yī)科大學(xué)附屬腫瘤醫(yī)院接診的55例患者納入研究，按照隨機(jī)數(shù)字表法均分為觀察組30例和對照組25例。對照組經(jīng)腹腔鏡子宮肌瘤剝除術(shù)+縮宮素聯(lián)合治療。觀察組經(jīng)腹腔鏡子宮肌瘤剝除術(shù)+馬來酸麥角新堿聯(lián)合治療。觀察2組術(shù)中出血量、手術(shù)時(shí)間、住院時(shí)間、手術(shù)前后的血紅蛋白下降情況、并發(fā)癥。結(jié)果 觀察組術(shù)中出血量、手術(shù)時(shí)間、住院時(shí)間、手術(shù)前后的血紅蛋白下降情況均顯著低于對照組（P<0.05），觀察組并發(fā)癥發(fā)生率顯著低于對照組（P<0.05）。結(jié)論 馬來酸麥角新堿在子宮肌瘤剔除術(shù)中應(yīng)用效果較好，可以改善患者術(shù)中出血量、降低手術(shù)前后的血紅蛋白下降情況、縮短手術(shù)時(shí)間、住院時(shí)間，降低并發(fā)癥發(fā)生率。

Objective To explore the application value of ergonovine maleate in myomectomy in.Methods 55 patients Received from July 2018 to November 2018 in our hospital were included in this study. According to the random number table Method, 30 cases in the observation group and 25 cases in the control group. The control group:Laparoscopic myomectomy + Oxytocin combined therapy. The observation group:Laparoscopic myomectomy + ergonovine maleate combined therapy. The amount of bleeding, the time of Operation, the time of hospitalization, Hemoglobin decline before and after surgery and the complications were observed. Results the intraoperative blood loss, hemoglobin decline before and after surgery, operative time and Hospitalization time in the observation group were lower than those in the control group (P<0.05), and the incidence of complications In the observation group was lower than that in the control group (P<0.05).Conclusion Good application effect in Laparoscopic myomectomy Ergonovine, can improve patients with bleeding volume, operation time, hospitalization time, hemoglobin decline before and after surgery, reduce the incidence of complications.